With President Donald Trump expected to levy tariffs on pharmaceuticals manufactured outside the United States, industry ...

Key regulators are not recommending Lilly’s Kisunla be cleared for the European market. The company says it plans to appeal ...

As U.S. President Donald Trump threatens a new round of tariffs as part of an onshoring push, Chinese President Xi Jinping is ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

The survey predicted the increase would happen within the next six months. Other industry news is on health care access in rural areas; Pfizer's alleged attempt to avoid taxes; and more.

In a report released today, Geoff Meacham from Citi maintained a Buy rating on Eli Lilly & Co (LLY – Research Report). The company’s shares ...

Billionaire Dalio, head of the world's largest hedge fund, is considered a global authority on investing in China. The bank ...

The bosses of some of the world's biggest companies met with Chinese President Xi Jinping in Beijing on Friday.

Potential US tariffs on pharmaceuticals could set off a ripple effect that extends far beyond the immediate price hikes, as ...

The FDA recently approved the first treatment in nearly 30 years for acute stroke, and the agency also approved a novel drug ...

Eli Lilly is expanding care offerings on its direct-to-consumer (DTC) platform LillyDirect, now offering connections to ...